VERU INC. Shares Outstanding (Cover Page)
VERU INC. (VERU) had Shares Outstanding (Cover Page) of 17.05 million shares as of 2026-08-06, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-06: Entity Common Stock, Shares Outstanding 17.05M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 16.05M shares.
- 2026-02-06: Entity Common Stock, Shares Outstanding 16.05M shares.
- 2025-12-12: Entity Common Stock, Shares Outstanding 16.05M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 17.05M shares 10-Q · filed 2026-08-10 |
| 2026-05-08 | 16.05M shares 10-Q · filed 2026-05-13 |
| 2026-02-06 | 16.05M shares 10-Q · filed 2026-02-11 |
| 2025-12-12 | 16.05M shares 10-K · filed 2025-12-17 |
| 2025-08-07 | 14.65M shares 10-Q · filed 2025-08-12 |
| 2025-05-05 | 146.58M shares 10-Q · filed 2025-05-08 |
| 2025-02-10 | 146.38M shares 10-Q · filed 2025-02-13 |
| 2024-12-12 | 146.38M shares 10-K · filed 2024-12-16 |
| 2024-08-05 | 146.38M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 146.38M shares 10-Q · filed 2024-05-08 |
| 2024-03-29 | 146.38M shares 10-Q · filed 2024-04-01 |
| 2023-12-05 | 93.67M shares 10-K/A · filed 2024-04-01 |
| 2023-08-08 | 90.28M shares 10-Q/A · filed 2023-11-15 |
| 2023-05-09 | 89.24M shares 10-Q · filed 2023-05-11 |
| 2023-02-06 | 80.66M shares 10-Q · filed 2023-02-09 |
| 2022-11-30 | 80.62M shares 10-K · filed 2022-12-05 |
| 2022-08-08 | 80.15M shares 10-Q · filed 2022-08-11 |
| 2022-05-09 | 80.07M shares 10-Q · filed 2022-05-12 |
| 2022-02-07 | 80.05M shares 10-Q · filed 2022-02-09 |
| 2021-11-29 | 80.03M shares 10-K · filed 2021-12-02 |
| 2021-08-09 | 79.85M shares 10-Q · filed 2021-08-12 |
| 2021-05-10 | 79.68M shares 10-Q · filed 2021-05-12 |
| 2021-02-08 | 71.91M shares 10-Q · filed 2021-02-10 |
| 2020-12-07 | 70.08M shares 10-K · filed 2020-12-10 |
| 2020-08-11 | 69.86M shares 10-Q · filed 2020-08-13 |
| 2020-05-11 | 66.10M shares 10-Q · filed 2020-05-13 |
| 2020-02-10 | 65.19M shares 10-Q · filed 2020-02-12 |
| 2019-12-10 | 65.04M shares 10-K · filed 2019-12-12 |
| 2019-08-05 | 65.04M shares 10-Q · filed 2019-08-08 |
| 2019-05-10 | 62.79M shares 10-Q · filed 2019-05-15 |
| 2019-02-11 | 62.78M shares 10-Q · filed 2019-02-13 |
| 2018-12-10 | 62.62M shares 10-K · filed 2018-12-13 |
| 2018-08-10 | 55.28M shares 10-Q · filed 2018-08-14 |
| 2018-05-08 | 53.51M shares 10-Q · filed 2018-05-11 |
| 2018-02-13 | 53.51M shares 10-Q · filed 2018-02-14 |
| 2017-12-21 | 53.21M shares 10-K · filed 2018-01-02 |
| 2017-08-04 | 53.21M shares 10-Q · filed 2017-08-09 |
| 2017-05-04 | 31.34M shares 10-Q · filed 2017-05-10 |
| 2017-02-08 | 31.34M shares 10-Q · filed 2017-02-09 |
| 2016-12-09 | 31.34M shares 10-K · filed 2016-12-12 |
| 2016-07-27 | 29.05M shares 10-Q · filed 2016-07-28 |
| 2016-04-27 | 29.05M shares 10-Q · filed 2016-04-28 |
| 2016-02-01 | 29.03M shares 10-Q · filed 2016-02-02 |
| 2015-11-27 | 29.02M shares 10-K · filed 2015-12-02 |
| 2015-07-29 | 28.76M shares 10-Q · filed 2015-07-30 |
| 2015-04-29 | 28.82M shares 10-Q · filed 2015-04-30 |
| 2015-02-02 | 28.81M shares 10-Q · filed 2015-02-03 |
| 2014-11-28 | 28.82M shares 10-K · filed 2014-12-02 |
| 2014-07-30 | 28.89M shares 10-Q · filed 2014-07-31 |
| 2014-04-30 | 28.88M shares 10-Q · filed 2014-05-01 |
| 2014-01-31 | 28.88M shares 10-Q · filed 2014-02-03 |
| 2013-11-29 | 28.73M shares 10-K · filed 2013-12-03 |
| 2013-07-31 | 28.68M shares 10-Q · filed 2013-08-01 |
| 2013-05-01 | 28.64M shares 10-Q · filed 2013-05-02 |
| 2013-01-29 | 28.67M shares 10-Q · filed 2013-01-30 |
| 2012-11-30 | 28.67M shares 10-K · filed 2012-12-04 |
| 2012-07-30 | 28.52M shares 10-Q · filed 2012-07-31 |
| 2012-04-30 | 27.92M shares 10-Q · filed 2012-05-01 |
| 2012-01-30 | 27.92M shares 10-Q · filed 2012-01-31 |
| 2011-12-01 | 27.88M shares 10-K · filed 2011-12-02 |
| 2011-08-05 | 27.73M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |